obesity. Orexigen Therapeutics

Orexigen Therapeutics: Light at the End of the Tunnel?
Motley Fool
Tue, 12/10/13 - 09:07 am
obesity. Orexigen Therapeutics
Contrave
Value Investing, Biotech Style
Motley Fool
Sat, 01/29/11 - 11:35 am
investors
Benlysta
Human Genome Sciences
GSK
Cell Therapeutics
obesity. Orexigen Therapeutics
Vertex Pharmaceuticals
Exelixis
FDA: Proposed Weight Loss Drug Contrave Raises Blood Pressure
WSJ
Sat, 12/4/10 - 12:33 pm
Takeda
Contrave
weight loss
obesity. Orexigen Therapeutics